Biotech HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO® August 17, 2026
Biotech Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain August 17, 2026
Biotech argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis August 17, 2026
Biotech Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update August 13, 2026
Biotech Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older August 13, 2026
Biotech Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update August 12, 2026
Biotech Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study August 12, 2026
Search
Biotech
August 17, 2026
August 17, 2026
August 17, 2026
August 17, 2026
August 15, 2026
August 13, 2026
August 13, 2026
August 12, 2026
August 12, 2026
August 12, 2026
